SinoReg

Natco Pharma Limited — China drug registrations and re-registration deadlines

12 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-09-28.

Approval numberProductCertificate expiresRe-registration deadline (Art. 82)
国药准字HJ20220023Oseltamivir Phosphate Capsules
磷酸奥司他韦胶囊
2027-03-282026-09-28
国药准字HJ20220024Oseltamivir Phosphate Capsules
磷酸奥司他韦胶囊
2027-03-282026-09-28
国药准字HJ20220025Oseltamivir Phosphate Capsules
磷酸奥司他韦胶囊
2027-03-282026-09-28
国药准字HJ20233124Abiraterone Acetate Tablets
醋酸阿比特龙片
2028-02-132027-08-13
国药准字HJ20230142Gefitinib Tablets
吉非替尼片
2028-12-042028-06-04
国药准字HJ20240055Doxorubicin Hydrochloride Liposome Injection
盐酸多柔比星脂质体注射液
2029-06-272028-12-27
国药准字HJ20240056Doxorubicin Hydrochloride Liposome Injection
盐酸多柔比星脂质体注射液
2029-06-272028-12-27
国药准字HJ20240120Ibrutinib Capsules
伊布替尼胶囊
2029-10-282029-04-28
国药准字HJ20240159Lanthanum Carbonate Chewable Tablets
碳酸镧咀嚼片
2029-12-052029-06-05
国药准字HJ20240160Lanthanum Carbonate Chewable Tablets
碳酸镧咀嚼片
2029-12-052029-06-05
国药准字HJ20250005Olaparib Tablets
奥拉帕利片
2030-01-072029-07-07
国药准字HJ20250006Olaparib Tablets
奥拉帕利片
2030-01-072029-07-07

Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.

All holders  ·  China re-registration deadline index